The Japan Sleep Apnea Devices Market was valued at $329.2 Million in 2025 and projected to reach to $574 Million by 2030, representing a compound annual growth rate of 8.3%. Japan's sleep apnea devices market is positioned for substantial expansion, growing from USD 329.2 million in 2025 to USD 574.0 million by 2030.
Japan's rapidly aging demographic, with over 29% of the population aged 65+, is significantly increasing sleep apnea prevalence and device adoption rates across the country.
Japan's world-class medical system and high diagnostic capabilities enable early detection and treatment of sleep disorders, supporting sustained market growth and device penetration.
At 8.3% CAGR from 2025-2030, Japan's market growth outpaces the global average of 7.6%, reflecting exceptional regional momentum and market maturity.
Increased public health campaigns and physician education in Japan are driving awareness of sleep apnea, leading to higher diagnosis rates and device market expansion.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ORAL APPLIANCES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.6% from 2025 to 2030 |
| Largest Segment | THERAPEUTIC DEVICES (Product) |
| Market Size Base Year (Billions) | ~USD 6.95 (2025) |
| Revenue Forecast (Billions) | ~USD 10.03 (2030) |
| Segments Covered | Product, Type |
2 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HENRY SCHEIN | United States | Public Company | Therapeutic – Oral Appliances,Therapeutic – PAP Devices (CPAP, APAP, BPAP),Therapeutic – Masks and Consumables, |
| ROSSMAX INTERNATIONAL LTD | Taiwan | Public Company | Therapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks, |
| SANOFI | Spain | Public Company | Therapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks, |
| DANAHER CORPORATION | United States | Public Company | Therapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Oral Appliances,Therapeutic – Masks, |
| RESMED | United States | Public Company | Therapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances, |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Therapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks and Interfaces,Therapeutic – Oral Appliances, |
| FISHER & PAYKEL HEALTHCARE LIMITED | New Zealand | Public Company | Therapeutic – PAP devices (CPAP, APAP, BPAP),Therapeutic – Masks and interfaces,Therapeutic – Oral appliances, |
| INSPIRE MEDICAL SYSTEMS, INC. | United States | Public Company | Therapeutic – Neurostimulation System (competes with PAP/Oral Appliances/Masks),Diagnostic-Linked Services (competes with PSG/Home Sleep Testing/Oximeter adjacencies), |
| SOMNOMED | Australia | Public Company | Therapeutic – Oral Appliances (SomnoDent portfolio, SomMorning Repositioner, SomnoBrux),Adjacencies – Cleaning and maintenance (SomTabs) and related accessories,Non-OSA dental protection (SomnoBrux-only use cases), |
| COMPUMEDICS LIMITED | Australia | Public Company | Diagnostic – PSG Systems (lab-based and ambulatory),Diagnostic – Home Sleep Testing & Wearables,Diagnostic – Oximetry and Ancillary Monitoring, |
| BMC | United States | Private Company | Therapeutic Devices (PAP, Oral Appliances, Masks),Diagnostic Devices (PSG, Home Sleep Testing, Oximeter),Healthcare IT / Workflow Enablement for Sleep Care, |
| PROSOMNUS SLEEP TECHNOLOGIES | United States | Private Company | Therapeutic – Oral Appliances,Therapeutic – PAP (CPAP, APAP, BPAP),Therapeutic – Masks, |
Henry Schein is a publicly traded United States company founded in 1932 with 25,000 employees.
Rossmax International Ltd is a publicly traded company based in Taiwan, founded in 1988.
Sanofi is a publicly traded pharmaceutical company based in Spain, founded in 1994 with 74,846 employees.
Danaher Corporation is a publicly traded United States company founded in 1969 with 59,000 employees.
ResMed is a publicly traded United States company founded in 1989 with 10,600 employees.
Koninklijke Philips N.V. is a publicly traded Dutch company founded in 1891 with 64,317 employees.
Fisher & Paykel Healthcare Limited is a publicly traded New Zealand company founded in 1934 with 7,396 employees.
Inspire Medical Systems, Inc. is a publicly traded United States company founded in 2007 with 1,333 employees.
SomnoMed is a publicly traded Australian company founded in 1987 with 300 employees.
Compumedics Limited is a publicly traded Australian company founded in 1987 with 175 employees.
BMC is a United States-based private company founded in 1980 with 6,700 employees.
ProSomnus Sleep Technologies is a United States-based private company founded in 2016 with 136 employees.
Japan's sleep apnea devices market was valued at USD 329.2 million in 2025 and is expected to reach USD 574.0 million by 2030.
Japan's sleep apnea devices market is projected to grow at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2030.
Key drivers include Japan's aging population, rising obesity rates, increased awareness of sleep disorders, strong reimbursement policies, and technological innovations in device design and comfort.
Japan's advanced healthcare infrastructure, robust reimbursement policies, well-established distribution networks, and emphasis on preventive care all support widespread adoption of sleep apnea diagnostic and therapeutic devices.
CPAP devices remain the dominant segment in Japan, though alternative therapies and portable diagnostic devices are gaining traction due to improved patient comfort and compliance features.
The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches and approvals, expansions, agreements, and partnerships of the leading players, the competitive landscape of the sleep apnea devices market is analyzed to evaluate market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The four steps involved in estimating the market size are
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 1 million, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| SOMNOmedcis AG (Germany) | Country Manager |
| ResMed (US) | Regional Sales Manager |
Both top-down and bottom-up approaches were used to estimate and validate the total size of sleep apnea devices in the market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Sleep apnea is a prevalent sleep disorder that is frequently undiagnosed, yet it poses significant health risks. This condition is characterized by intermittent cessation of breathing, which can last from several seconds to minutes, or by irregular breathing patterns. The most predominant form is obstructive sleep apnea (OSA), where anatomical or physiological obstructions impede airflow during sleep. Continuous positive airway pressure (CPAP) devices are commonly used to deliver air at elevated pressure through the nasal passages, effectively counteracting upper airway obstructions and facilitating normal respiration. These interventions are crucial for mitigating the associated morbidities linked with untreated sleep apnea.
Full forecast, segment splits, and company analysis for all Sleep Apnea Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report